463 related articles for article (PubMed ID: 15791625)
21. Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver.
Ohshita H; Tateno C
Methods Mol Biol; 2017; 1506():91-100. PubMed ID: 27830547
[TBL] [Abstract][Full Text] [Related]
22. Practical evaluation of a mouse with chimeric human liver model for hepatitis C virus infection using an NS3-4A protease inhibitor.
Kamiya N; Iwao E; Hiraga N; Tsuge M; Imamura M; Takahashi S; Miyoshi S; Tateno C; Yoshizato K; Chayama K
J Gen Virol; 2010 Jul; 91(Pt 7):1668-77. PubMed ID: 20164258
[TBL] [Abstract][Full Text] [Related]
23. Human cord blood cells transplanted into chronically damaged liver exhibit similar characteristics to functional hepatocytes.
Kakinuma S; Asahina K; Okamura K; Teramoto K; Tateno C; Yoshizato K; Tanaka Y; Yasumizu T; Sakamoto N; Watanabe M; Teraoka H
Transplant Proc; 2007; 39(1):240-3. PubMed ID: 17275513
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic efficacy of human hepatocyte transplantation in a SCID/uPA mouse model with inducible liver disease.
Douglas DN; Kawahara T; Sis B; Bond D; Fischer KP; Tyrrell DL; Lewis JT; Kneteman NM
PLoS One; 2010 Feb; 5(2):e9209. PubMed ID: 20174638
[TBL] [Abstract][Full Text] [Related]
25. Critical role of natural killer cells in the rejection of human hepatocytes after xenotransplantation into immunodeficient mice.
Kawahara T; Douglas DN; Lewis J; Lund G; Addison W; Tyrrell DL; Churchill TA; Kneteman NM
Transpl Int; 2010 Sep; 23(9):934-43. PubMed ID: 20180929
[TBL] [Abstract][Full Text] [Related]
26. The uPA(+/+)-SCID mouse with humanized liver as a model for in vivo metabolism of 4-androstene-3,17-dione.
Lootens L; Van Eenoo P; Meuleman P; Leroux-Roels G; Delbeke FT
Drug Metab Dispos; 2009 Dec; 37(12):2367-74. PubMed ID: 19741039
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of mouse fetal liver epithelial cells with high in vivo repopulation capacity.
Nierhoff D; Ogawa A; Oertel M; Chen YQ; Shafritz DA
Hepatology; 2005 Jul; 42(1):130-9. PubMed ID: 15895427
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of humanized cDNA-uPA/SCID mice for the study of hepatitis B virus and hepatitis C virus virology.
Uchida T; Imamura M; Kan H; Hiraga N; Hayes CN; Tsuge M; Abe-Chayama H; Aikata H; Makokha GN; Miki D; Ochi H; Ishida Y; Tateno C; Chayama K
J Gen Virol; 2017 May; 98(5):1040-1047. PubMed ID: 28141486
[TBL] [Abstract][Full Text] [Related]
29. Chimeric mouse model for the infection of hepatitis B and C viruses.
Tesfaye A; Stift J; Maric D; Cui Q; Dienes HP; Feinstone SM
PLoS One; 2013; 8(10):e77298. PubMed ID: 24155939
[TBL] [Abstract][Full Text] [Related]
30. Morphologic characterization of PhoenixBio (uPA+/+/SCID) humanized liver chimeric mouse model.
Peterson RA; Krull DL; Brown HR; de Serres M
Drug Metab Lett; 2010 Aug; 4(3):180-4. PubMed ID: 20642451
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus replication in mice with chimeric human livers.
Mercer DF; Schiller DE; Elliott JF; Douglas DN; Hao C; Rinfret A; Addison WR; Fischer KP; Churchill TA; Lakey JR; Tyrrell DL; Kneteman NM
Nat Med; 2001 Aug; 7(8):927-33. PubMed ID: 11479625
[TBL] [Abstract][Full Text] [Related]
32. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.
Galun E; Nahor O; Eid A; Jurim O; Rose-John S; Blum HE; Nussbaum O; Ilan E; Daudi N; Shouval D; Reisner Y; Dagan S
Virology; 2000 May; 270(2):299-309. PubMed ID: 10792989
[TBL] [Abstract][Full Text] [Related]
33. Transplantation of engineered chimeric liver with autologous hepatocytes and xenobiotic scaffold.
Hata T; Uemoto S; Fujimoto Y; Murakami T; Tateno C; Yoshizato K; Kobayashi E
Ann Surg; 2013 Mar; 257(3):542-7. PubMed ID: 22691372
[TBL] [Abstract][Full Text] [Related]
34. A novel cDNA-uPA/SCID/Rag2
Uchida T; Teraoka Y; Imamura M; Abe-Chayama H; Makokha GN; Hayes CN; Aikata H; Hamamura S; Ishida Y; Tateno C; Shirouzu T; Kawai S; Tanaka Y; Ohdan H; Okada S; Chayama K
J Viral Hepat; 2023 Mar; 30(3):262-272. PubMed ID: 36575861
[TBL] [Abstract][Full Text] [Related]
35. Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes.
Dandri M; Burda MR; Zuckerman DM; Wursthorn K; Matschl U; Pollok JM; Rogiers X; Gocht A; Köck J; Blum HE; von Weizsäcker F; Petersen J
J Hepatol; 2005 Jan; 42(1):54-60. PubMed ID: 15629507
[TBL] [Abstract][Full Text] [Related]
36. Human liver-specific nanocarrier in a novel mouse xenograft model bearing noncancerous human liver tissue.
Matsuura Y; Yagi H; Matsuda S; Itano O; Aiura K; Kuroda S; Ueda M; Kitagawa Y
Eur Surg Res; 2011; 46(2):65-72. PubMed ID: 21178358
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.
Lütgehetmann M; Bornscheuer T; Volz T; Allweiss L; Bockmann JH; Pollok JM; Lohse AW; Petersen J; Dandri M
Gastroenterology; 2011 Jun; 140(7):2074-83, 2083.e1-2. PubMed ID: 21376046
[TBL] [Abstract][Full Text] [Related]
38. Cross-species transmission of gibbon and orangutan hepatitis B virus to uPA/SCID mice with human hepatocytes.
Sa-Nguanmoo P; Tanaka Y; Ratanakorn P; Sugiyama M; Murakami S; Payungporn S; Sommanustweechai A; Mizokami M; Poovorawan Y
Virus Res; 2011 Jun; 158(1-2):209-15. PubMed ID: 21510984
[TBL] [Abstract][Full Text] [Related]
39. Generation of humanized animal livers using embryoid body-derived stem cell transplant.
Locke JE; Sun Z; Warren DS; Sheets TP; Holzer H; Shamblott MJ; Montgomery RA; Cameron AM
Ann Surg; 2008 Sep; 248(3):487-93. PubMed ID: 18791369
[TBL] [Abstract][Full Text] [Related]
40. Strong antiviral activity of the new l-hydroxycytidine derivative, l-Hyd4FC, in HBV-infected human chimeric uPA/SCID mice.
Volz T; Lütgehetmann M; Allweiss L; Warlich M; Bierwolf J; Pollok JM; Petersen J; Matthes E; Dandri M
Antivir Ther; 2012; 17(4):623-31. PubMed ID: 22368233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
